Caffeine Citrate Oral Solution
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Caffeine Citrate Oral Solution is a sterile aqueous solution containing Caffeine and citric acid. It contains NLT 90.0% and NMT 110.0% of the labeled amount of caffeine citrate (C14H18N8O9). It contains no bacteriostat or other preservative.
2 IDENTIFICATION
A. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
B. IDENTIFICATION TESTS-GENERAL, Citrate 191): Meets the requirements
C.
Solution A: Transfer 4 g of potassium iodide to a 100-mL volumetric flask, and add 10 mL of water. Shake until the potassium iodide is dissolved. Add 2 g of iodine to the volumetric flask, and shake until dissolved. Dilute with water to volume.
Sample solution: 5.0 mL of Oral Solution
Analysis: Transfer the Sample solution to a 25-ml centrifuge tube, and add 5 drops of Solution A. Add 0.5 mL of 2.0 M hydrochloric acid.
Acceptance criteria: A brown precipitate that dissolves on neutralization with 0.5 mL of sodium hydroxide TS is produced.
3 ASSAY
PROCEDURE
Mobile phase: Acetonitrile, tetrahydrofuran, and 0.01 M sodium acetate (5:4:191) adjusted with glacial acetic acid to a pH of 4.5
Theophylline stock solution: 0.02 mg/mL of theophylline in water
Standard solution: 0.2 mg/ml. of USP Caffeine RS and 0.004 mg/ml. of theophylline from Theophylline stock solution in water
Sample solution: Nominally 0.4 mg/mL of caffeine citrate (equivalent to 0.2 mg/mL of caffeine) from Oral Solution in water prepared as follows. Transfer a volume of Oral Solution, equivalent to 50 mg of caffeine, to a 250-mL volumetric flask. Dilute with water to volume, pass through a polyvinylidene difluoride or equivalent membrane of 0.45-µm pore size, and use the filtrate.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 275 nm
Column: 4.6-mm x 15-cm; 5-µm packing L1
Flow rate: 1 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
[NOTE-See Table 1 for the relative retention times.]
Suitability requirements
Resolution: NLT 6.0 between theophylline and caffeine
Tailing factor: NMT 2.0 each for the theophylline and caffeine
Relative standard deviation: NMT 2.0% for caffeine
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (CA), in mg/mL, of caffeine citrate in the Sample solution:
Result = (ru /rs ) × Cs × (Mr1 /Mr2 )
ru = peak response from the Sample solution
rs = peak response from the Standard solution
Cs = concentration of USP Caffeine RS in the Standard solution (mg/mL)
Mr1 = molecular weight of caffeine citrate, 386.31
Mr2 = molecular weight of caffeine, 194.19
Calculate the percentage of the labeled amount of caffeine citrate (C14H18N8O9) in the portion of Oral Solution taken:
Result = (CA /Cu ) × 100
CA = concentration of caffeine citrate in the Sample solution
Cu = nominal concentration of caffeine citrate in the Sample solution
Acceptance criteria: 90.0%–110.0%
4 IMPURITIES
ORGANIC IMPURITIES
Mobile phase, Theophylline stock solution, Standard solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay
Sensitivity solution: 5 µg/mL of caffeine and 0.1 µg/mL of theophylline from the Standard solution in water
System suitability
Sample: Sensitivity solution
Suitability requirements
Sensitivity: The theophylline peak is discernible.
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each impurity in the portion of Oral Solution taken:
Result = (ru /rs ) × (Cs /CA ) × (Mr1 /Mr2 ) × (1/F) × 100
ru = peak response of each impurity from the Sample solution
rs = peak response of caffeine from the Standard solution
Cs = concentration of USP Caffeine RS in the Standard solution (mg/mL)
CA = concentration of caffeine citrate in the Sample solution as determined in the Assay
Mr1 = molecular weight of caffeine citrate, 386.31
Mr2 = molecular weight of caffeine, 194.19
F = relative response factor, (see Table 1)
Acceptance criteria: See Table 1.
Table 1
Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
| Theobromine | 0.4 | 1.13 | 0.10 |
| Paraxanthine | 0.6 | 0.909 | 0.10 |
| Theophylline | 0.7 | 1.10 | 0.10 |
| Caffeine | 1.0 | - | - |
| Any individual impurity | - | 1.0 | 0.10 |
| Total impurities | - | - | 0.1 |
5 SPECIFIC TESTS
Sterility Tests 〈71〉: It meets the requirements of the Test for Sterility of the Product to Be Examined, Membrane Filtration.
pH 〈791〉: 4.2–5.2
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in single-dose, tight containers, and store at a temperature between 15°–30°.
USP Reference Standards 〈11〉
USP Caffeine RS

